Blog

The Future of Toxicology: An Industry Case Study

The Future of Toxicology: An Industry Case Study

Blog

This article describes some new in vitro approaches to toxicology, as well as current initiatives, to facilitate the verification of methods and conclusions, and to enhance data sharing and scientific discovery.

Read More

Uncovering the Dark Matter of Microbiota

Uncovering the Dark Matter of Microbiota

Blog

We spoke to Dirk Löffert, Ph.D., CEO of Biomillenia, to learn about some of the challenges of isolating live bacterial species, and how microbiome-on-a-chip technology can help overcome some of these.

Read More

Unlocking The Full Potential of Organoids

Unlocking The Full Potential of Organoids

Blog

To learn about the importance of the extracellular matrix and some of the limitations of current organoid culture systems, we spoke to Colin Sanctuary, CEO and founder of QGel, a spin-out from EPFL.

Read More

In Vitro Toxicology Testing: Dismantling the Barriers via Collaboration

In Vitro Toxicology Testing: Dismantling the Barriers via Collaboration

Blog

Promoting the adoption of in vitro toxicity testing is an important undertaking, so we should strive to overcome the barriers preventing its widespread adoption. Already, collaborative efforts have made progress in this regard, and research advances are increasingly demonstrating the potential of in vitro biomimetic liver models.

Read More

In Vitro Toxicology Testing: The Barriers to Progression and Adoption

In Vitro Toxicology Testing: The Barriers to Progression and Adoption

Blog

The field of toxicology as a whole is at a crossroads where current and future technologies are enabling better predictions of toxicity before a substance is released for human consumption or exposure. While a few barriers remain, we are making progress towards overcoming them, from both technical and policy perspectives.

Read More

Cell-based Imaging and Screening Applications

Cell-based Imaging and Screening Applications

Blog

BioStatus develops and supplies products for cell-based imaging, cytometry and screening applications. We met with Roy Edward, Director at BioStatus during the High Content and Phenotypic Screening 2017 event to learn more.

Read More

A New Approach to Treating Hair Loss

A New Approach to Treating Hair Loss

Blog

We spoke to Lee Buckler, President and CEO of RepliCel, to learn about the cellular mechanisms responsible for hair loss, and the potential that cell therapy could offer to treat the condition.

Read More

Cell Culture: Moving from 2D to 3D and Beyond

Cell Culture: Moving from 2D to 3D and Beyond

Blog

To learn about the limitations of 2D cell culture models, the range of 3D tools available, and some of the advantages they can bring to researchers, we spoke to Dr. Richard Eglen, Vice President and General Manager of Corning Life Sciences.

Read More

A New Weapon in the War Against Antibiotic Resistance

A New Weapon in the War Against Antibiotic Resistance

Blog

We spoke to Bruce Savage, CEO at GFC Diagnostics to learn more about the MicroScreen test.

Read More

Verification of Scientific Methods and Results

Verification of Scientific Methods and Results

Blog

To find out about the sbv IMPROVER project and its aims, we spoke to Dr Julia Hoeng, Director of Systems Toxicology at PMI Research & Development.

Read More